Table 3.
Patient | Target MDRO | Terminal Clean Protocol | Patient- Environment | Environment-Patient | Indeterminate | Presence of Molecularly Related Isolates | Presence of Molecularly Discordant MDRO Isolatesb |
---|---|---|---|---|---|---|---|
A | MRSA | Bleach | X | X | |||
B | MRSA | Bleach | X | X | X | ||
C | VRE | Quat. | X | X | |||
D | VREc | Bleach + UV | X | ||||
E | VREc | Bleach + UV | X | ||||
F | VREc | Bleach + UV | X | ||||
G | VRE | Bleach | X | X | |||
H | CDI | Bleach | X | X | X | ||
I | CDI | Bleach | X | X | |||
J | CDI | Quat. | X | X | X | ||
K | CDI | Quat. | X | X | X | ||
L | CDI | Quat. + UV | X | X | |||
Total | 12 | 4 (33%) | 4 (33%) | 4 (33%) | 6 (50%) | 7(58%) |
Note. MRSA, methicillin resistant Staphylococcus aureus; VRE, vancomycin-resistant enterococci; MDR ABC, multidrug-resistant Acinetobacter baumanii complex; Quat., quaternary ammonium; CDI, Clostridium difficile infection.
Terminal cleaning protocol used for disinfecting the room prior to admission: bleach, bleach+UV irradiation, Quat., Quat.+UV irradiation.
Subjects could have both molecularly related and molecularly discordant transfer events if>1 ribotype of a target MDRO species was identified.
Molecular relatedness unknown due to noninterpretable pulsed-field gel electrophoresis (PFGE).